25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Faes Farma SA
Buy, Hold or Sell?

Let's analyze Faes Farma SA together

I guess you are interested in Faes Farma SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Faes Farma SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Faes Farma SA

I send you an email if I find something interesting about Faes Farma SA.

Quick analysis of Faes Farma SA (30 sec.)










What can you expect buying and holding a share of Faes Farma SA? (30 sec.)

How much money do you get?

How much money do you get?
€0.20
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€2.13
Expected worth in 1 year
€2.92
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
€0.97
Return On Investment
27.6%

For what price can you sell your share?

Current Price per Share
€3.53
Expected price per share
€3.3165231671554 - €3.7294436268068
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Faes Farma SA (5 min.)




Live pricePrice per Share (EOD)

€3.53

Intrinsic Value Per Share

€-1.78 - €0.44

Total Value Per Share

€0.35 - €2.57

2. Growth of Faes Farma SA (5 min.)




Is Faes Farma SA growing?

Current yearPrevious yearGrowGrow %
How rich?$720.2m$653.9m$66.3m9.2%

How much money is Faes Farma SA making?

Current yearPrevious yearGrowGrow %
Making money$99.7m$97.1m$2.6m2.6%
Net Profit Margin20.4%20.4%--

How much money comes from the company's main activities?

3. Financial Health of Faes Farma SA (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Faes Farma SA? (5 min.)

Welcome investor! Faes Farma SA's management wants to use your money to grow the business. In return you get a share of Faes Farma SA.

What can you expect buying and holding a share of Faes Farma SA?

First you should know what it really means to hold a share of Faes Farma SA. And how you can make/lose money.

Speculation

The Price per Share of Faes Farma SA is €3.53. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Faes Farma SA.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Faes Farma SA, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €2.13. Based on the TTM, the Book Value Change Per Share is €0.20 per quarter. Based on the YOY, the Book Value Change Per Share is €0.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Faes Farma SA.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.329.1%0.329.1%0.318.8%0.287.9%0.205.8%
Usd Book Value Change Per Share0.216.0%0.216.0%0.226.3%0.216.0%0.164.6%
Usd Dividend Per Share0.051.4%0.051.4%0.061.8%0.051.4%0.030.9%
Usd Total Gains Per Share0.267.5%0.267.5%0.298.1%0.267.4%0.205.5%
Usd Price Per Share3.43-3.43-3.81-4.05-3.52-
Price to Earnings Ratio10.70-10.70-12.20-15.04-19.32-
Price-to-Total Gains Ratio13.00-13.00-13.26-15.91-19.51-
Price to Book Ratio1.48-1.48-1.81-2.27-2.62-
Price-to-Total Gains Ratio13.00-13.00-13.26-15.91-19.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.832874
Number of shares260
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.05
Usd Book Value Change Per Share0.210.21
Usd Total Gains Per Share0.260.26
Gains per Quarter (260 shares)68.6467.53
Gains per Year (260 shares)274.56270.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
15322226550220260
2106443540100440530
3159665815150660800
421288610902008801070
52651108136525111001340
63181329164030113201610
73711551191535115401880
84241773219040117602150
94771994246545119802420
105302216274050122002690

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.01.00.094.7%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.01.00.094.7%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Faes Farma SA

About Faes Farma SA

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide. It operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It offers products for various therapeutic areas. The company also provides animal nutrition and health products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.

Fundamental data was last updated by Penke on 2024-07-19 14:05:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Faes Farma SA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Faes Farma SA earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Faes Farma SA to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 20.4% means that €0.20 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Faes Farma SA:

  • The MRQ is 20.4%. The company is making a huge profit. +2
  • The TTM is 20.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ20.4%TTM20.4%0.0%
TTM20.4%YOY20.4%0.0%
TTM20.4%5Y19.7%+0.7%
5Y19.7%10Y17.4%+2.3%
1.1.2. Return on Assets

Shows how efficient Faes Farma SA is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Faes Farma SA to the Drug Manufacturers - Specialty & Generic industry mean.
  • 11.8% Return on Assets means that Faes Farma SA generated €0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Faes Farma SA:

  • The MRQ is 11.8%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 11.8%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ11.8%TTM11.8%0.0%
TTM11.8%YOY12.3%-0.5%
TTM11.8%5Y12.6%-0.7%
5Y12.6%10Y11.4%+1.1%
1.1.3. Return on Equity

Shows how efficient Faes Farma SA is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Faes Farma SA to the Drug Manufacturers - Specialty & Generic industry mean.
  • 13.9% Return on Equity means Faes Farma SA generated €0.14 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Faes Farma SA:

  • The MRQ is 13.9%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 13.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.9%TTM13.9%0.0%
TTM13.9%YOY14.9%-1.0%
TTM13.9%5Y15.0%-1.1%
5Y15.0%10Y13.8%+1.2%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Faes Farma SA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Faes Farma SA is operating .

  • Measures how much profit Faes Farma SA makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Faes Farma SA to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 23.0% means the company generated €0.23  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Faes Farma SA:

  • The MRQ is 23.0%. The company is operating efficient. +1
  • The TTM is 23.0%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ23.0%TTM23.0%0.0%
TTM23.0%YOY23.3%-0.3%
TTM23.0%5Y23.4%-0.4%
5Y23.4%10Y21.4%+1.9%
1.2.2. Operating Ratio

Measures how efficient Faes Farma SA is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.77 means that the operating costs are €0.77 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Faes Farma SA:

  • The MRQ is 0.770. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.770. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.770TTM0.7700.000
TTM0.770YOY0.767+0.003
TTM0.7705Y0.765+0.005
5Y0.76510Y0.784-0.020
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Faes Farma SA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Faes Farma SA is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.34 means the company has €3.34 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Faes Farma SA:

  • The MRQ is 3.344. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.344. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.344TTM3.3440.000
TTM3.344YOY3.317+0.027
TTM3.3445Y3.375-0.031
5Y3.37510Y3.263+0.112
1.3.2. Quick Ratio

Measures if Faes Farma SA is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Faes Farma SA to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.01 means the company can pay off €2.01 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Faes Farma SA:

  • The MRQ is 2.008. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.008. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.008TTM2.0080.000
TTM2.008YOY2.286-0.278
TTM2.0085Y2.233-0.224
5Y2.23310Y2.276-0.043
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Faes Farma SA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Faes Farma SA assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Faes Farma SA to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.15 means that Faes Farma SA assets are financed with 14.5% credit (debt) and the remaining percentage (100% - 14.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Faes Farma SA:

  • The MRQ is 0.145. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.145. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.145TTM0.1450.000
TTM0.145YOY0.170-0.025
TTM0.1455Y0.160-0.015
5Y0.16010Y0.172-0.011
1.4.2. Debt to Equity Ratio

Measures if Faes Farma SA is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Faes Farma SA to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 17.0% means that company has €0.17 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Faes Farma SA:

  • The MRQ is 0.170. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.170. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.170TTM0.1700.000
TTM0.170YOY0.205-0.035
TTM0.1705Y0.191-0.021
5Y0.19110Y0.211-0.020
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Faes Farma SA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Faes Farma SA generates.

  • Above 15 is considered overpriced but always compare Faes Farma SA to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 10.70 means the investor is paying €10.70 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Faes Farma SA:

  • The EOD is 11.955. Based on the earnings, the company is underpriced. +1
  • The MRQ is 10.702. Based on the earnings, the company is underpriced. +1
  • The TTM is 10.702. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD11.955MRQ10.702+1.253
MRQ10.702TTM10.7020.000
TTM10.702YOY12.200-1.498
TTM10.7025Y15.045-4.343
5Y15.04510Y19.320-4.276
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Faes Farma SA:

  • The EOD is -899.844. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -805.526. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -805.526. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-899.844MRQ-805.526-94.318
MRQ-805.526TTM-805.5260.000
TTM-805.526YOY42.279-847.804
TTM-805.5265Y-131.089-674.437
5Y-131.08910Y-52.446-78.643
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Faes Farma SA is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.48 means the investor is paying €1.48 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Faes Farma SA:

  • The EOD is 1.656. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.483. Based on the equity, the company is underpriced. +1
  • The TTM is 1.483. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.656MRQ1.483+0.174
MRQ1.483TTM1.4830.000
TTM1.483YOY1.814-0.331
TTM1.4835Y2.274-0.791
5Y2.27410Y2.617-0.343
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Faes Farma SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1960.1960%0.206-5%0.195+1%0.150+31%
Book Value Per Share--2.1312.1310%1.935+10%1.729+23%1.330+60%
Current Ratio--3.3443.3440%3.317+1%3.375-1%3.263+2%
Debt To Asset Ratio--0.1450.1450%0.170-15%0.160-9%0.172-15%
Debt To Equity Ratio--0.1700.1700%0.205-17%0.191-11%0.211-19%
Dividend Per Share--0.0470.0470%0.058-20%0.044+6%0.030+55%
Eps--0.2950.2950%0.288+3%0.258+15%0.188+57%
Free Cash Flow Per Share---0.004-0.0040%0.083-105%0.092-104%0.100-104%
Free Cash Flow To Equity Per Share---0.118-0.1180%0.024-596%0.001-10521%0.046-357%
Gross Profit Margin--0.7370.7370%0.737+0%0.702+5%0.677+9%
Intrinsic Value_10Y_max--0.442--------
Intrinsic Value_10Y_min---1.784--------
Intrinsic Value_1Y_max--0.088--------
Intrinsic Value_1Y_min---0.009--------
Intrinsic Value_3Y_max--0.232--------
Intrinsic Value_3Y_min---0.175--------
Intrinsic Value_5Y_max--0.335--------
Intrinsic Value_5Y_min---0.500--------
Market Cap1098708941.760+10%983546814.720983546814.7200%1092483961.920-10%1160211742.579-15%1007917610.794-2%
Net Profit Margin--0.2040.2040%0.2040%0.197+3%0.174+17%
Operating Margin--0.2300.2300%0.233-1%0.234-2%0.214+7%
Operating Ratio--0.7700.7700%0.767+0%0.765+1%0.784-2%
Pb Ratio1.656+10%1.4831.4830%1.814-18%2.274-35%2.617-43%
Pe Ratio11.955+10%10.70210.7020%12.200-12%15.045-29%19.320-45%
Price Per Share3.530+10%3.1603.1600%3.510-10%3.728-15%3.238-2%
Price To Free Cash Flow Ratio-899.844-12%-805.526-805.5260%42.279-2005%-131.089-84%-52.446-93%
Price To Total Gains Ratio14.518+10%12.99712.9970%13.265-2%15.912-18%19.507-33%
Quick Ratio--2.0082.0080%2.286-12%2.233-10%2.276-12%
Return On Assets--0.1180.1180%0.123-4%0.126-6%0.114+4%
Return On Equity--0.1390.1390%0.149-7%0.150-7%0.138+0%
Total Gains Per Share--0.2430.2430%0.265-8%0.239+2%0.180+35%
Usd Book Value--720264344.200720264344.2000%653954538.200+10%584209261.000+23%449412945.740+60%
Usd Book Value Change Per Share--0.2130.2130%0.224-5%0.212+1%0.162+31%
Usd Book Value Per Share--2.3142.3140%2.101+10%1.877+23%1.444+60%
Usd Dividend Per Share--0.0510.0510%0.063-20%0.048+6%0.033+55%
Usd Eps--0.3210.3210%0.312+3%0.280+15%0.205+57%
Usd Free Cash Flow---1325761.800-1325761.8000%28057072.000-105%31226305.040-104%33883691.960-104%
Usd Free Cash Flow Per Share---0.004-0.0040%0.090-105%0.100-104%0.109-104%
Usd Free Cash Flow To Equity Per Share---0.128-0.1280%0.026-596%0.001-10521%0.050-357%
Usd Market Cap1192978168.963+10%1067935131.4231067935131.4230%1186219085.853-10%1259757910.093-15%1094396941.800-2%
Usd Price Per Share3.833+10%3.4313.4310%3.811-10%4.047-15%3.516-2%
Usd Profit--99787191.60099787191.6000%97174756.800+3%86928930.840+15%63671094.840+57%
Usd Revenue--489878214.400489878214.4000%476399093.200+3%439991567.720+11%352896509.480+39%
Usd Total Gains Per Share--0.2640.2640%0.287-8%0.260+2%0.195+35%
 EOD+5 -3MRQTTM+0 -0YOY+15 -215Y+21 -1510Y+26 -10

3.2. Fundamental Score

Let's check the fundamental score of Faes Farma SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1511.955
Price to Book Ratio (EOD)Between0-11.656
Net Profit Margin (MRQ)Greater than00.204
Operating Margin (MRQ)Greater than00.230
Quick Ratio (MRQ)Greater than12.008
Current Ratio (MRQ)Greater than13.344
Debt to Asset Ratio (MRQ)Less than10.145
Debt to Equity Ratio (MRQ)Less than10.170
Return on Equity (MRQ)Greater than0.150.139
Return on Assets (MRQ)Greater than0.050.118
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Faes Farma SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.886
Ma 20Greater thanMa 503.508
Ma 50Greater thanMa 1003.571
Ma 100Greater thanMa 2003.356
OpenGreater thanClose3.515
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Net Interest Income  -303-93-396-196-592185-407803396



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets776,029
Total Liabilities112,680
Total Stockholder Equity662,355
 As reported
Total Liabilities 112,680
Total Stockholder Equity+ 662,355
Total Assets = 776,029

Assets

Total Assets776,029
Total Current Assets290,286
Long-term Assets485,743
Total Current Assets
Cash And Cash Equivalents 34,647
Short-term Investments 13,104
Net Receivables 113,506
Inventory 128,656
Other Current Assets 373
Total Current Assets  (as reported)290,286
Total Current Assets  (calculated)290,286
+/-0
Long-term Assets
Property Plant Equipment 280,615
Goodwill 56,083
Intangible Assets 128,123
Long-term Assets Other 14,654
Long-term Assets  (as reported)485,743
Long-term Assets  (calculated)479,475
+/- 6,268

Liabilities & Shareholders' Equity

Total Current Liabilities86,818
Long-term Liabilities25,862
Total Stockholder Equity662,355
Total Current Liabilities
Short-term Debt 19,523
Short Long Term Debt 17,290
Accounts payable 35,439
Other Current Liabilities 31,856
Total Current Liabilities  (as reported)86,818
Total Current Liabilities  (calculated)104,108
+/- 17,290
Long-term Liabilities
Capital Lease Obligations 6,606
Long-term Liabilities Other 241
Long-term Liabilities  (as reported)25,862
Long-term Liabilities  (calculated)6,847
+/- 19,015
Total Stockholder Equity
Common Stock31,622
Retained Earnings 165,806
Accumulated Other Comprehensive Income 486,567
Other Stockholders Equity -21,640
Total Stockholder Equity (as reported)662,355
Total Stockholder Equity (calculated)662,355
+/-0
Other
Capital Stock31,622
Cash and Short Term Investments 47,751
Common Stock Shares Outstanding 310,729
Liabilities and Stockholders Equity 776,029
Net Debt -10,751
Net Invested Capital 679,645
Net Working Capital 203,468
Property Plant and Equipment Gross 367,943
Short Long Term Debt Total 23,896



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
24,208,364
24,574,552
176,910
198,010
199,287
216,042
232,434
272,433
275,015
235,965
297,097
291,120
286,844
285,156
267,233
290,677
331,223
430,241
480,804
493,673
564,150
641,764
725,670
776,029
776,029725,670641,764564,150493,673480,804430,241331,223290,677267,233285,156286,844291,120297,097235,965275,015272,433232,434216,042199,287198,010176,91024,574,55224,208,364
   > Total Current Assets 
0
0
0
72,802
76,873
72,633
78,083
96,994
80,132
49,498
87,708
83,558
82,890
85,040
88,677
113,468
153,656
169,834
217,581
222,989
290,007
293,711
313,211
290,286
290,286313,211293,711290,007222,989217,581169,834153,656113,46888,67785,04082,89083,55887,70849,49880,13296,99478,08372,63376,87372,802000
       Cash And Cash Equivalents 
613,529
344,080
2,533
5,954
12,003
5,763
1,572
5,318
7,509
531
2,154
6,058
4,929
7,966
6,719
25,552
58,819
43,269
76,038
52,853
91,210
70,254
66,411
34,647
34,64766,41170,25491,21052,85376,03843,26958,81925,5526,7197,9664,9296,0582,1545317,5095,3181,5725,76312,0035,9542,533344,080613,529
       Short-term Investments 
4,870,065
4,657,986
18,334
12,213
14,249
13,994
16,589
15,452
9,443
11,449
10,216
6,339
5,599
6,705
6,552
7,355
7,184
70
371
1,330
1,926
3,154
17,689
13,104
13,10417,6893,1541,9261,330371707,1847,3556,5526,7055,5996,33910,21611,4499,44315,45216,58913,99414,24912,21318,3344,657,9864,870,065
       Net Receivables 
4,384,438
4,923,638
32,114
33,332
26,918
28,823
34,223
47,599
35,728
23,184
39,048
38,271
41,534
38,872
42,238
46,258
49,061
72,159
77,061
97,352
105,280
112,852
114,111
113,506
113,506114,111112,852105,28097,35277,06172,15949,06146,25842,23838,87241,53438,27139,04823,18435,72847,59934,22328,82326,91833,33232,1144,923,6384,384,438
       Other Current Assets 
51,460
15,190
62
45,648
14,440
42,972
51,060
63,254
9,443
4,545
10,315
38,623
41,906
39,276
42,498
46,536
49,360
76,625
81,867
8,206
8,433
13,652
12,943
373
37312,94313,6528,4338,20681,86776,62549,36046,53642,49839,27641,90638,62310,3154,5459,44363,25451,06042,97214,44045,6486215,19051,460
   > Long-term Assets 
0
0
0
125,208
122,414
143,409
154,351
175,439
194,883
186,467
209,389
207,562
203,954
200,116
178,556
177,209
177,567
260,407
263,223
270,684
274,143
348,053
412,459
485,743
485,743412,459348,053274,143270,684263,223260,407177,567177,209178,556200,116203,954207,562209,389186,467194,883175,439154,351143,409122,414125,208000
       Property Plant Equipment 
2,918,210
3,030,379
20,724
23,937
25,028
26,828
28,624
30,816
33,311
24,327
32,070
29,157
25,719
23,062
22,531
30,433
38,408
57,648
67,057
83,932
95,245
139,628
205,804
280,615
280,615205,804139,62895,24583,93267,05757,64838,40830,43322,53123,06225,71929,15732,07024,32733,31130,81628,62426,82825,02823,93720,7243,030,3792,918,210
       Goodwill 
0
0
0
84,972
85,101
90,989
94,700
20,543
17,348
5,337
17,348
17,348
17,348
17,348
17,348
17,348
17,348
81,385
53,941
61,503
52,643
65,723
51,776
56,083
56,08351,77665,72352,64361,50353,94181,38517,34817,34817,34817,34817,34817,34817,3485,33717,34820,54394,70090,98985,10184,972000
       Intangible Assets 
6,420,866
6,102,582
65,886
84,972
85,101
90,989
89,036
104,919
112,967
42,924
114,865
110,451
91,383
87,782
81,478
76,190
72,800
77,867
111,737
106,990
112,880
113,688
126,911
128,123
128,123126,911113,688112,880106,990111,73777,86772,80076,19081,47887,78291,383110,451114,86542,924112,967104,91989,03690,98985,10184,97265,8866,102,5826,420,866
       Long-term Assets Other 
0
0
0
16,299
12,285
25,592
31,027
1,800
1,803
58,482
147
7,889
7,149
8,255
8,102
8,905
8,734
1,620
1,921
2,880
3,476
4,704
1,550
14,654
14,6541,5504,7043,4762,8801,9211,6208,7348,9058,1028,2557,1497,88914758,4821,8031,80031,02725,59212,28516,299000
> Total Liabilities 
6,914,864
7,472,492
68,500
80,148
68,885
84,419
92,582
121,375
118,307
113,039
131,589
123,508
102,027
87,349
38,607
36,342
46,335
109,466
120,650
80,019
91,273
103,698
123,391
112,680
112,680123,391103,69891,27380,019120,650109,46646,33536,34238,60787,349102,027123,508131,589113,039118,307121,37592,58284,41968,88580,14868,5007,472,4926,914,864
   > Total Current Liabilities 
6,466,923
7,046,933
50,094
64,159
56,016
71,298
78,222
102,355
65,880
57,538
81,504
74,880
52,886
51,250
30,065
31,102
37,945
56,450
103,751
72,279
84,685
79,307
94,428
86,818
86,81894,42879,30784,68572,279103,75156,45037,94531,10230,06551,25052,88674,88081,50457,53865,880102,35578,22271,29856,01664,15950,0947,046,9336,466,923
       Short-term Debt 
0
0
0
25,741
23,179
0
0
65,768
35,563
31,149
46,138
43,570
25,135
23,760
3,281
1,161
1,632
6,995
51,486
11,592
12,248
14,283
28,285
19,523
19,52328,28514,28312,24811,59251,4866,9951,6321,1613,28123,76025,13543,57046,13831,14935,56365,7680023,17925,741000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
33,961
2,063
0
2,295
7,697
51,876
7,611
10,431
13,619
26,517
17,290
17,29026,51713,61910,4317,61151,8767,6972,29502,06333,9610000000000000
       Accounts payable 
2,870,004
2,374,122
11,537
22,236
16,401
30,630
33,017
31,214
25,747
8,232
28,062
23,023
16,116
16,288
16,494
18,067
20,297
33,171
36,179
36,185
41,973
37,925
36,594
35,439
35,43936,59437,92541,97336,18536,17933,17120,29718,06716,49416,28816,11623,02328,0628,23225,74731,21433,01730,63016,40122,23611,5372,374,1222,870,004
       Other Current Liabilities 
3,594,811
2,336,322
21,731
16,182
16,436
40,668
45,205
5,373
4,570
13,318
2,818
8,287
36,839
34,983
13,669
14,124
18,909
25,488
68,107
24,502
59
27,099
57,834
31,856
31,85657,83427,0995924,50268,10725,48818,90914,12413,66934,98336,8398,2872,81813,3184,5705,37345,20540,66816,43616,18221,7312,336,3223,594,811
   > Long-term Liabilities 
0
0
0
15,989
12,869
13,121
14,360
19,020
52,427
55,501
50,085
48,628
49,141
36,099
8,542
5,240
8,390
53,016
16,899
7,740
6,588
24,391
28,963
25,862
25,86228,96324,3916,5887,74016,89953,0168,3905,2408,54236,09949,14148,62850,08555,50152,42719,02014,36013,12112,86915,989000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,645
2,161
4,400
0
04,4002,1611,64500000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
696
701
705
687
500
157
35
241
241351575006877057016960000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
7,575
7,030
7,276
6,487
4,579
9,630
12,367
15,907
20,302
23,164
0
023,16420,30215,90712,3679,6304,5796,4877,2767,0307,5750000000000000
> Total Stockholder Equity
17,243,630
17,064,963
108,351
117,782
130,318
131,603
139,832
151,038
156,688
122,926
165,500
167,604
184,809
197,799
228,619
254,327
284,883
320,243
359,883
412,968
471,395
536,528
601,076
662,355
662,355601,076536,528471,395412,968359,883320,243284,883254,327228,619197,799184,809167,604165,500122,926156,688151,038139,832131,603130,318117,782108,35117,064,96317,243,630
   Common Stock
1,101,921
1,212,113
8,013
8,903
9,893
11,130
12,521
14,227
16,005
18,006
19,507
20,482
20,482
21,978
23,504
24,792
25,497
26,155
27,009
27,815
28,524
29,742
31,078
31,622
31,62231,07829,74228,52427,81527,00926,15525,49724,79223,50421,97820,48220,48219,50718,00616,00514,22712,52111,1309,8938,9038,0131,212,1131,101,921
   Retained Earnings 
3,355,162
4,761,241
10,084
13,370
16,910
127,550
135,533
54,602
55,277
18,161
42,696
33,240
35,803
39,668
42,911
47,870
52,365
60,923
73,255
90,632
104,268
127,779
147,532
165,806
165,806147,532127,779104,26890,63273,25560,92352,36547,87042,91139,66835,80333,24042,69618,16155,27754,602135,533127,55016,91013,37010,0844,761,2413,355,162
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,460
1,460
1,460
0
01,4601,4601,46000000000000000000000
   Treasury Stock000000-3,746-3,307-3,208-3,359-2,299-2,299-2,29900000000000
   Other Stockholders Equity 
0
0
0
108,879
120,425
-7,077
-8,222
82,209
85,406
86,759
103,297
113,882
128,524
136,153
162,204
181,665
207,021
233,165
259,619
-3,804
-3,804
-3,853
-15,126
-21,640
-21,640-15,126-3,853-3,804-3,804259,619233,165207,021181,665162,204136,153128,524113,882103,29786,75985,40682,209-8,222-7,077120,425108,879000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue451,168
Cost of Revenue-154,050
Gross Profit297,118297,118
 
Operating Income (+$)
Gross Profit297,118
Operating Expense-193,370
Operating Income103,868103,748
 
Operating Expense (+$)
Research Development5,203
Selling General Administrative33,238
Selling And Marketing Expenses24,130
Operating Expense193,37062,571
 
Net Interest Income (+$)
Interest Income1,080
Interest Expense-383
Other Finance Cost-301
Net Interest Income396
 
Pretax Income (+$)
Operating Income103,868
Net Interest Income396
Other Non-Operating Income Expenses-
Income Before Tax (EBT)102,852104,884
EBIT - interestExpense = 103,485
103,061
92,285
Interest Expense383
Earnings Before Interest and Taxes (EBIT)103,868103,235
Earnings Before Interest and Taxes (EBITDA)123,266
 
After tax Income (+$)
Income Before Tax102,852
Tax Provision-11,159
Net Income From Continuing Ops91,69391,693
Net Income91,902
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses347,420
Total Other Income/Expenses Net-1,016-396
 

Technical Analysis of Faes Farma SA
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Faes Farma SA. The general trend of Faes Farma SA is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Faes Farma SA's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Faes Farma SA.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.573711827957 < 3.5979872427984 < 3.7294436268068.

The bearish price targets are: 3.4366976744186 > 3.41 > 3.3165231671554.

Tweet this
Faes Farma SA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Faes Farma SA. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Faes Farma SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Faes Farma SA. The current macd is -0.00195009.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Faes Farma SA price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Faes Farma SA. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Faes Farma SA price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Faes Farma SA Daily Moving Average Convergence/Divergence (MACD) ChartFaes Farma SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Faes Farma SA. The current adx is 21.49.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Faes Farma SA shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Faes Farma SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Faes Farma SA. The current sar is 3.416732.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Faes Farma SA Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Faes Farma SA. The current rsi is 50.89. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Faes Farma SA Daily Relative Strength Index (RSI) ChartFaes Farma SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Faes Farma SA. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Faes Farma SA price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Faes Farma SA Daily Stochastic Oscillator ChartFaes Farma SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Faes Farma SA. The current cci is 67.28.

Faes Farma SA Daily Commodity Channel Index (CCI) ChartFaes Farma SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Faes Farma SA. The current cmo is 4.39709072.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Faes Farma SA Daily Chande Momentum Oscillator (CMO) ChartFaes Farma SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Faes Farma SA. The current willr is -40.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Faes Farma SA is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Faes Farma SA Daily Williams %R ChartFaes Farma SA Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Faes Farma SA.

Faes Farma SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Faes Farma SA. The current atr is 0.05703523.

Faes Farma SA Daily Average True Range (ATR) ChartFaes Farma SA Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Faes Farma SA. The current obv is 832,290.

Faes Farma SA Daily On-Balance Volume (OBV) ChartFaes Farma SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Faes Farma SA. The current mfi is 61.98.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Faes Farma SA Daily Money Flow Index (MFI) ChartFaes Farma SA Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Faes Farma SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-17STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-06-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-06-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Faes Farma SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Faes Farma SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.886
Ma 20Greater thanMa 503.508
Ma 50Greater thanMa 1003.571
Ma 100Greater thanMa 2003.356
OpenGreater thanClose3.515
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Faes Farma SA with someone you think should read this too:
  • Are you bullish or bearish on Faes Farma SA? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Faes Farma SA? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Faes Farma SA

I send you an email if I find something interesting about Faes Farma SA.


Comments

How you think about this?

Leave a comment

Stay informed about Faes Farma SA.

Receive notifications about Faes Farma SA in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.